Vaccination News

An early spike in influenza cases in Chile and other countries in the Southern Hemisphere could serve as a warning for the rest of the world, according to experts.

Pfizer reported topline data from a phase 3 trial of its respiratory syncytial virus vaccine for pregnant women, which showed high vaccine efficacy in newborns.

Healio spoke with Meg Doherty, MD, MPH, PhD, Director Global HIV, Hepatitis and STI Programmes at WHO, about elimination efforts for hepatitis D, including how hepatitis D would be affected by WHO Global Hepatitis Elimination goals and what U.S. physician can do to help work towards hepatitis elimination.

CDC Director Rochelle P. Walensky, MD, has experienced a rebound of COVID-19 symptoms after being treated with Paxlovid, the agency announced Monday.

ANAHEIM, Calif. — COVID-19 vaccination status had no impact on certain aspects of pregnancies facilitated through assisted reproductive technology, according to study data.

Influenza reached epidemic levels in Chile months earlier than a typical influenza season, just like in several other Southern Hemisphere countries, researchers reported.

The COVID-19 pandemic has highlighted areas in which the medical community can improve patient care and access to treatment for numerous conditions, including hepatitis D virus.

The FDA recently authorized a booster dose of Novavax’s COVID-19 vaccine in adults aged 18 years and older.

WASHINGTON — Should ACAM2000 be a first-line vaccine in the current monkeypox outbreak? That was the topic of a pro/con debate during a “clinical controversies” session at IDWeek.

WASHINGTON — Three late-breaking studies offered a promising glimpse of respiratory syncytial virus vaccines in the pipeline for older adults — including the RSVPreF3 OA vaccine, which showed an overall vaccine efficacy of about 83%.